The Australasian ILD Registry (AILDR), a bi-national registry of patients with all ILD subtypes, has the potential to address major research questions including around new therapeutics and biomarkers of disease. A pilot phase of the Registry, based at just four sites in Australia and comprising 1,061 patients, has just reported baseline data. Participants were mostly ...
ILD Registry to deliver local and global benefit
By Mardi Chapman
27 Oct 2020